Newsroom
Field notes from the Atlantic.
Dispatches, partnerships and conversations from the summit floor, filed as they land.
AI Summit 2026: What Is Still Ahead, and Who It Is For
Two thirds of the AI summit 2026 calendar is already over. The events left from September to December, verified dates, and which job each one does.
AI Education Summit: What Separates One From a Trade Show
None of the top AI education summits are trade shows. Here is the real tell, four examples, and what to check before you book one.
Dangers of AI in Healthcare: The 2026 Incident Record
The top health technology hazard of 2026 is a chatbot nobody procured. The documented dangers of AI in healthcare, and where each one gets in.
Responsible AI in Healthcare: What You Have to Prove
Responsible AI in healthcare is now a certifiable claim: five standard areas, seven elements, and the 92% vs 44% gap that decides who can prove it.
AI in Healthcare Administration: Where the Savings Go
AI in healthcare administration cuts manual work and raises the bill. The 2026 evidence on prior authorization, coding intensity and who keeps the gain.
AI Governance in Healthcare: Who Signs Off, and When
84% of health systems have an AI governance committee. Only 29% enforce sign-off policies. What AI governance in healthcare has to do to be real.
AI in Regulatory Affairs: What It Does and Cannot Do
The FDA now reads submissions with AI too. What AI in regulatory affairs measurably does, where the guidance draws its line, and what it cannot decide.
AI Regulation Ban: The Two Things People Mean
In the US an AI regulation ban means banning the states from regulating. In the EU it means the uses Article 5 forbids. Both are live in 2026.
Generative AI in Healthcare: The Deployment Record
Not a use case list. What happened when generative AI was switched on in real hospitals in 2026: adoption curves, hallucination rates and evaluation gaps.
The Future of AI in Healthcare: What Is Already Scheduled
Not forecasts. The future of AI in healthcare read off what is already dated: an FDA GenAI docket, 15 to 20 Phase III readouts, and a validation gap.
AI Education Conferences: Who They Are Actually For
Four unrelated events share the name. Research, institutional strategy, classroom PD or trade show: how to tell which AI education conference is yours.
Ethics of AI in Healthcare: The Questions Asked First
The ethics of AI in healthcare stopped being a principles debate on 2 August 2026. Six questions, who asks each one, and what counts as an answer.
Disadvantages of AI in Healthcare: The Cost When It Works
The disadvantages of AI in healthcare are not its failures. They are what a health system pays when the tool works exactly as designed. 2026 evidence.
Risks of AI in Healthcare: Ranked by Who Carries Them
The 2026 evidence on the risks of AI in healthcare, sorted by who absorbs the harm: patients, clinicians, institutions, and the risks nobody owns.
Should AI Be Regulated? The Evidence on Both Sides
Only one in ten Americans want no AI rules. The real 2026 argument is not whether AI should be regulated but with which instrument, and at what cost.
AI Regulatory Compliance: What Is Actually In Force Now
The EU AI Act deadlines moved and Colorado's law was repealed. What AI regulatory compliance requires today, and the controls that survive the fights.
AI Impact Summit: What Actually Changed After Delhi
The India AI Impact Summit promised measurable outcomes. What it delivered, what nobody tracks afterwards, and four tests for any event claiming impact.
Research to Commercialization: The Steps Nobody Budgets
The route from research to commercialization, priced. The FY2025 funnel numbers, the patent bill you now inherit, and the grants that fund TRL 4 to 6.
Cost of AI in Healthcare: What the Quotes Leave Out
The cost of AI in healthcare is quoted as a build price. Here is the running cost, the reimbursement gap, and the only rigorously measured return so far.
What Actually Happens at an AI Business Summit
Four unrelated formats call themselves an AI business summit. What each one actually delivers, what it really costs, and how to judge before you book.
AI in Healthcare: What the 2026 Evidence Shows
Adoption numbers, what holds up outside the study, the deskilling signal, and who actually pays: an evidence map of AI in healthcare in 2026.
What Is Sovereign AI? A Guide for Everyone Else
Sovereign AI explained without the vendor gloss: what it means, how it differs from data sovereignty, and what a country can realistically control.
EnerGaia Institute secures 11 IP-fund approvals with EX-IX
Our partner EnerGaia Institute earned 11 EUIPO SME Fund approvals to expand its IP portfolio in collaboration with EX-IX — building the future of intellectual property.
The Atlantic becomes a laboratory — EX-AI-Summit returns to Las Palmas
Three days, three rooms, one conversation: how the 2026 edition reframes research, policy and capital around the islands.
Bali opens its digital residency sandbox to founders
A live policy environment for the first cohort of resident startups — apply from the summit floor.
Frontier compute finds early backers in Las Palmas
A new island-based fund signals that the next generation of founders should look beyond the usual rooms.
Island states lead a sovereign data blueprint for climate adaptation
Why the next decade of climate work will be measured in harbours, not data centres.